Skincare Leader Celebrates Anniversary with the Launch of Three New Antioxidant Technologies for Scar Care, Skin Health and Visible Anti-Aging

AMITYVILLE, N.Y. & SIMI VALLEY, Calif.--(BUSINESS WIRE)--Topix Brands, the leading independent provider of efficacious, custom, and branded skincare is proud to be celebrating the 40th Anniversary of Topix Pharmaceuticals this year. Since it was founded over 40 years ago, Topix Pharmaceuticals has been the #1 practice branded skincare provider, partnering with over 6000+ global physicians and serving dermatologists and physicians worldwide.

“We are so excited to celebrate 40 years of Topix Pharmaceuticals,” said Topix Brands CEO & President Brenda Wu.“Topix is the culmination of 40 years of partnering with dermatologists bringing scientific skincare breakthroughs and we now look towards even greater advances with new technologies, potent antioxidants, and enablers such as greater customization and e-commerce offerings.”

In celebration of 40 years, Topix is excited to announce the launch of its newest physician dispensed technologies, including a Vitamin C E Green Tea Polyphenol Serum, Scar Treatment Silicone Gel and Daily Scar Care SPF 45. All three products bring advanced innovation to their categories and provide highly potent and effective formulas.

Board certified medical and cosmetic dermatologist Dr. Mary Kober says, “I love the new Vitamin C E Green Tea Polyphenol Serum. It pairs so well with many of the medical procedures we conduct in our office, and I recommend it to many of my patients who are concerned with anti-aging and are looking for a more natural but effective way to diminish the look of wrinkles and fine lines. Topix Pharmaceuticals are true innovators, and that is very apparent through the technology of their rapid release delivery system that delivers the product both faster and deeper into the skin.”

Board certified dermatologist and MOHS surgeon Dr. Dustin Portela says, “The new Daily Scar Care with 15% Micronized Zinc Oxide and the new Scar Treatment skincare gel are products that my patients love. Both have potent antioxidant green tea polyphenols paired with medical grade silicone, which help to hydrate, soothe, and allow skin to heal so that my patients see less visible darkening of scar tissue and loss of elasticity. I see the results in my patients’ scars fading, softening, and smoothing out.”

Topix Brands is led by CEO & President Brenda Wu, who has built a strong team to lead the business into the future including CMO Barbara Roll, COO Rogerio Barbosa, and new CFO Paul Carousso who collectively bring 20 years of industry experience.

Topix Pharmaceuticals empowers physicians with its unique offering of advanced technologies paired with physician practice customization and e-commerce capabilities. Topix is committed to proven skin science, built on decades of knowledge and longstanding close partnerships within the medical community. Topix Pharmaceuticals was founded in 1981 with the mission of developing and customizing the highest quality skincare products for dermatologists. Over the last 40+ years, Topix Brands has become an independent pioneer and leader in professional and clean skincare with a differentiated portfolio of clinically proven products and brands. Topix builds and establishes brands with credible experts transforming skincare with breakthrough technologies, clinically proven formulations and unparalleled scientific and consumer expertise. Topix’s family of clinical and consumer-facing brands includes Replenix™, Dr. Zenovia Skincare™, ClarityRx™, DERMA-E™, the #1 and fastest growing facial care brand in the natural channel, and Think, the highest Environmental Working Group (EWG) rated science backed clean sun care. Over the last five years Topix Brands has experienced significant growth and has similarly invested in a growing team of over 575 employees.

Topix Brands is backed by New Mountain Capital, a growth-oriented investment firm that currently manages more than $20 billion in assets. New Mountain Capital invested in Topix to provide equity capital to execute a growth strategy, including both organic and acquisition-led growth.

For more information on Topix Brands, please visit: http://www.topixbrands.com/.

For more information on Topix Pharmaceuticals, please visit: http://www.topixpharm.com/.

PR Contact: AMP3 PR, Ashley Lutzker (212)-677-2929 ashley@amp3pr.com